✦ LIBER ✦

Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?

✍ Scribed by Zachary S Zumsteg; Michael J Zelefsky

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Androgen Deprivation Therapy o

✍ M.H. Stenmark; F.Y. Feng; D.A. Hamstra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Dose-escalated radiation therapy for int

✍ Stanley L. Liauw; Janine Fricano; David Correa; Ralph R. Weichselbaum; Ashesh B. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Continued Benefit to Androgen Deprivatio

✍ Matthew H. Stenmark; Kevin Blas; Schuyler Halverson; Howard M. Sandler; Felix Y. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 475 KB

Risk-Adapted Androgen Deprivation and Es

✍ Zapatero, A. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 287 KB

Long-term vs. Short-term Androgen Depriv

✍ A. Zapatero; A. Guerrero; X. Maldonado; A. Alvarez; A. Cabeza; C. Gonzalez San S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

The addition of low-dose-rate brachyther

✍ Mark Shilkrut; Gregory S. Merrick; P. William McLaughlin; Matthew H. Stenmark; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB